Literature DB >> 24553958

Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.

Vikas Khullar1, Ankur Jain, Maryam Sattari.   

Abstract

Designer drugs represent an increasingly popular form of recreational substance abuse, especially amongst young adults. The two classes of designer drugs that have recently risen to prominence are the synthetic cannabinoids and synthetic cathinones. These substances are not detected by conventional drug screening methods and can often be associated with serious health consequences, including seizures, renal failure and death. Thus, clinicians should be familiar with the signs, symptoms, and toxicities associated with the use of these substances, and maintain a high level of suspicion for synthetic drugs as an alternative means of "getting high." We present a case of a 20-year-old college student who presented to the emergency department with altered mental status and severe agitation who later admitted to using bath salts. The goal of this article is to raise awareness about these new designer drugs, their clinical presentation, and management of their intoxication.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24553958      PMCID: PMC4099455          DOI: 10.1007/s11606-014-2802-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  34 in total

Review 1.  Synthetic cathinones (bath salts): legal status and patterns of abuse.

Authors:  Jennifer A Fass; Andrea D Fass; Angela S Garcia
Journal:  Ann Pharmacother       Date:  2012-02-28       Impact factor: 3.154

2.  Myocardial infarction associated with use of the synthetic cannabinoid K2.

Authors:  Arshid Mir; Adebisi Obafemi; Amy Young; Colin Kane
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

3.  Bath salts as a "legal high".

Authors:  Carin Smith; Anthony P Cardile; Michael Miller
Journal:  Am J Med       Date:  2011-04-22       Impact factor: 4.965

4.  Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants.

Authors:  T E Wilens; J Biederman; T J Spencer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-01       Impact factor: 8.829

5.  Triggering myocardial infarction by marijuana.

Authors:  M A Mittleman; R A Lewis; M Maclure; J B Sherwood; J E Muller
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

6.  Emergency department visits after use of a drug sold as "bath salts"--Michigan, November 13, 2010-March 31, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-20       Impact factor: 17.586

Review 7.  The "new" marijuana.

Authors:  Daina L Wells; Carol A Ott
Journal:  Ann Pharmacother       Date:  2011-02-15       Impact factor: 3.154

8.  Acute cannabis intoxication mimicking brugada-like ST segment abnormalities.

Authors:  Marcos Daccarett; Mouhanad Freih; Christian Machado
Journal:  Int J Cardiol       Date:  2007-02-08       Impact factor: 4.164

9.  Synthetic cannabinoid and marijuana exposures reported to poison centers.

Authors:  M B Forrester; K Kleinschmidt; E Schwarz; A Young
Journal:  Hum Exp Toxicol       Date:  2012-08-02       Impact factor: 2.903

10.  Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".

Authors:  Ulrich S Zimmermann; Patricia R Winkelmann; Max Pilhatsch; Josef A Nees; Rainer Spanagel; Katja Schulz
Journal:  Dtsch Arztebl Int       Date:  2009-07-03       Impact factor: 5.594

View more
  3 in total

Review 1.  Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Authors:  Eun Yong Chung; Hye Jin Cha; Hyun Kyu Min; Jaesuk Yun
Journal:  Arch Pharm Res       Date:  2021-04-02       Impact factor: 4.946

Review 2.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

Review 3.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.